Impact of PTRIA (Patient Test Result Information Act) on patient follow up management.
Autor: | Glushko T; Johns Hopkins University School of Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Diagnostic Radiology, 601 N. Caroline Street, JHOC 3235-A, Baltimore, MD 21287, United States of America. Electronic address: taglushko@gmail.com., Teytelboym O; Mercy Catholic Medical Center, Radiology Department, 1500 Lansdowne Ave, Darby, PA 19023, United States of America., Cook T; Hospital of the University of Pennsylvania, Department of Radiology, 3400 Spruce Street, 1, Silverstein Ste. 130, Philadelphia, PA 19104, United States of America. Electronic address: https://twitter.com/asset25. |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical imaging [Clin Imaging] 2021 Nov; Vol. 79, pp. 20-23. Date of Electronic Publication: 2021 Mar 22. |
DOI: | 10.1016/j.clinimag.2021.03.015 |
Abstrakt: | Objective: We aim to study if direct patient notification in accordance with the Patient Test Results Information Act (Act 112) in Pennsylvania leads to decreased loss to follow up and prompt management of actionable imaging findings. Methods: For this IRB-approved study, radiology reports were randomly identified using the Nuance mPower™ search engine. The actionable finding group (prior to Act-112) contained 300 patients for which a voice notification was sent by radiologists to alert ordering physicians about significant imaging findings. The PTRIA group (after Act-112) contained 300 patients who were mailed a standardized letter one day after the final report was issued. The electronic medical records were reviewed to evaluate how patients were managed. Results: There was no difference in loss to follow up rates and time to follow up completion between the two groups. In both groups, 34% of patients were lost to follow up in transition of care from generalists to specialists; 24% cases were lost to follow up when imaging findings were not in the area of the initial ordering provider expertise. Conclusion: The goal of Act 112 is to increase patients' role in the timely management of their significant medical conditions and prevent medical errors, specifically loss to follow up. Our study suggests that presumed patients' awareness does not contribute to improved follow up rates or decreased time to a follow up visit. 13% of patients are lost to follow up in both groups. A tracking system is required to prevent delayed management of the significant findings. (Copyright © 2021 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |